Table 4 Characteristics of patients and tissue subgroups stratified by HR and HER2 status
From: Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situ
Tissue subgroups | No. of samples (%) | Patient age (years) | |
|---|---|---|---|
Mean (Median) | Range | ||
DCIS | 64 (100%) | 55.9 (57) | 29-80 |
DCIS (ER+)a | 38 (59.4%) | 53.9 (54) | 29-80 |
DCIS (HER2+)b | 15 (23.4%) | 55.9 (57) | 35-69 |
DCIS (TN)c | 11 (17.2%) | 62.5 (64) | 55-74 |
IDC | 76 (100%) | 56.1 (56) | 28-88 |
IDC (ER+)a | 38 (50.0%) | 57.8 (56) | 29-88 |
IDC (HER2+)b | 14 (18.4%) | 53.4 (53) | 32-88 |
IDC (TN )c | 24 (31.6%) | 54.9 (58) | 28-77 |